An univariate Cox regression analysis of clinicopathologic parameters and TRA16 expression showed that TNM stage, tumor size, lymph node metastasis, tumor thrombus, cell differentiation, and TRA16 expression were significantly associated with overall survival of NSCLC patients (Table III). The gene discussed is NR2C2AP; the disease is non-small cell lung carcinoma.